Se você tiver sido prescrito um droga perigosa ou recebeu um dispositivo médico com defeito - como um…

Algum tempo atrás, nós te trouxemos um article about Takeda Pharmaceuticals…

IN August, when Takeda's patent on the diabetic drug Actos expired, the Food and Drug Administration (FDA) granted three pharmaceutical firms – Mylan, Ranbaxy and Teva – authorization  to market…

It is no secret that the large pharmaceutical corporations have been caught with their pants down on numerous occasions over the past several years – and the situation just keeps getting worse.…

Em agosto passado, ainda foi publicado um outro estudo que demonstrou o aumento do risco de câncer de bexiga resultante do uso prolongado de tiazolidinedione drugs such as Actos and Avandia.…

Recentemente, a US Food and Drug Administration aprovou uma forma genérica da droga diabética, Actos – despite the fact that…

É uma má notícia para a Takeda Pharmaceuticals, a empresa de biotecnologia japonesa que fabrica o medicamento para diabetes tipo 2 - Actos - ...

Um estudo recente publicado no British Medical Journal once again demonstrates a connection between use of the diabetes drug Actos (pioglitazone) and bladder cancer. Furthermore, a…

A recent study in the British Medical Journal confirms that Actos is associated with an increased risk of bladder cancer, making the drug a very risky option for Type 2 diabetics.  The study,…

This story isn't exactly new – it came out in the wake of an American Diabetes Association  conference in San Diego in the summer of 2011 – but even now, several months later, relatively few…